ArticleCancer research communications2025

Novel Pretreatment Autoantibodies Correlate with Enfortumab Vedotin-Related Dermatologic Events in Patients with Advanced Urothelial Cancer.

Evangelia Vlachou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.